$SLXP Company News SP shifts to ‘good news is good

New Post Public Reply Private Reply Replies (0) Message Board

Dec 13, 2013 at 12:17 PM

$SLXP Company News

S&P shifts to ‘good news is good news’ backdrop 12:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
FDA clears Salix anti-diarrheal for HIV patients 6:59 a.m. Jan. 1, 2013 - MarketWatch.com
Salix Pharmaceuticals profit rises 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
Hot Stocks to watch 6:27 a.m. Aug. 9, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 10:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 9:46 a.m. July 30, 2012 - Val Brickates Kennedy
LNKD trade provides a teachable moment 11:02 p.m. March 21, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 4:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 5:17 p.m. Nov. 9, 2011 - Kate Gibson
S&P 500 nails trendline resistance 10:44 a.m. Oct. 7, 2011 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:46 p.m. Feb. 24, 2011 - Kate Gibson
Salix takes center stage in drug-stock trading 12:53 p.m. Feb. 24, 2011 - Val Brickates Kennedy
Salix plunges on FDA setback 10:14 a.m. Feb. 24, 2011 - Val Brickates Kennedy
European drug stocks need a shot in the arm 2:41 a.m. Jan. 13, 2011 - Simon Kennedy
Weak economic data chip away at the technicals 10:00 a.m. Aug. 19, 2010 - Michael Ashbaugh
Thursday's biggest gaining and declining stocks 3:52 p.m. March 25, 2010 - MarketWatch
Genzyme, Poniard drop; Salix, BioMarin jump 12:48 p.m. March 25, 2010 - Val Brickates Kennedy
Now is a good time to buy stocks 12:01 a.m. March 12, 2010 - Kevin Marder

Progenics: Investors Should Remain Cautious Heading Into The Relistor Panel 9:10 a.m. Dec. 5, 2013 - Seeking Alpha
Valeant, Akorn Power Drugmakers Up IBD Industry Ranks 4:59 p.m. Dec. 3, 2013 - Investors Business Daily
Salix Commences Cash Tender Offer for Outstanding Shares of Santarus at $32.00/Share 6:04 a.m. Dec. 3, 2013 - benzinga.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Investors Expect too Much of Salix 6:00 a.m. Dec. 2, 2013 - TheStreet.com
Jazz, Salix Secure Drugmakers' Hold On Leadership 4:49 p.m. Nov. 21, 2013 - Investors Business Daily
2013's Big Winners Having A Rough Week 3:28 a.m. Nov. 21, 2013 - Seeking Alpha
Salix Receives FDA CDRH Approval for Additional Injection Techniques for Deflux 6:04 a.m. Nov. 18, 2013 - benzinga.com
Santarus: To Hold Or Take Profits Now? 8:40 p.m. Nov. 16, 2013 - Seeking Alpha
New Lifetime High Today: Salix Pharmaceuticals (SLXP) 9:46 a.m. Nov. 15, 2013 - TheStreet.com
Narrower Q3 Loss at Progenics - Analyst Blog 9:50 a.m. Nov. 14, 2013 - Zacks.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Salix Pharmaceuticals - Fresh Highs On The Santaurus Deal 3:03 p.m. Nov. 11, 2013 - Seeking Alpha
Narrower-than-Expected Loss at ArQule - Analyst Blog 11:40 a.m. Nov. 11, 2013 - Zacks.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
What Does Salix Really Want With Santarus, And Should You Buy? 3:27 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals: Santarus Acquisition Fortifies Position In Maturing Gastrointestinal Therapeutics Market 1:42 a.m. Nov. 11, 2013 - Seeking Alpha

Salix Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Santarus 7:01 a.m. Dec. 10, 2013 - BusinessWire
District Court Ruling, Cash Tender Offers, Celebration Events, Conference Presentations, and Repurchase Programs - Research Report on AstraZeneca, Salix, Health Net, Volcano and Portola 8:00 a.m. Dec. 9, 2013 - PR Newswire
Salix Pharmaceuticals Commences Cash Tender Offer for All Outstanding Shares of Santarus 7:01 a.m. Dec. 3, 2013 - BusinessWire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
Court Orders, Stock Price Movements, FDA Approvals and Strategic Collaborations - Research Report on Johnson & Johnson, Santarus, Salix, St. Jude Medical, and Covance 8:00 a.m. Nov. 21, 2013 - PR Newswire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection With Sale of the Company to Salix Pharmaceuticals, Ltd. -- SNTS 2:59 p.m. Nov. 18, 2013 - GlobeNewswire
Salix Announces Approval of Additional Injection Techniques for Deflux(R) 7:00 a.m. Nov. 18, 2013 - BusinessWire
Before the Bell Scans: Zoetis Inc., Avanir Pharma, Actavis PLC, and Salix Pharmaceuticals Ltd 8:01 a.m. Nov. 13, 2013 - PR Newswire
Financial Results, New Appointments, and Stock Price Movements - Research Report on Salix Pharmaceuticals, Cigna, St. Jude Medical, Zimmer, and CareFusion 8:00 a.m. Nov. 13, 2013 - PR Newswire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 12:31 p.m. Nov. 11, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. 11:31 a.m. Nov. 11, 2013 - PR Newswire
Critical Alerts For Salix Pharmaceuticals, Endo Pharmaceuticals, Nektar Therapeutics, Riverbed Technology, and Ubiquiti Networks Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Nov. 8, 2013 - PR Newswire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Nov. 8, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Nov. 8, 2013 - PR Newswire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Nov. 8, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Nov. 8, 2013 - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Nov. 8, 2013 - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Nov. 8, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viedoc and Bioforum Unite: Clinical Data Innovation

Revamping Clinical Trials with Data Integration It doesn't take a Wall Street wizard to understand that in today's research game, having data is only half the battle—using it effectively is where the rubber meets the road. Enter Viedoc and Bioforum, two names that are well-acquainted with the grind of the clinical research world. These seasoned pros have joined forces,...

Service Pros Adds Windshield Repair to Lineup

Revving Up the Service Engine Alright, folks, buckle up because Service Pros Auto Glass, our local go-to for windshield replacements, is cranking up their game. They're stepping into the windshield repair arena across Florida and South Carolina, aiming to save you a buck and keep you safe behind the wheel. That's a double win if you ask me. A Closer Look at the Details...

CNOOC Limited's 2026 Surge: New Projects, New Heights

Production Peaks and New Discoveries Over in the bustling corridors of oil and gas, CNOOC Limited is making some strong waves. Why? Because they’ve hit historical peaks in production in the first three quarters of 2026. We’re talking about a net production of 593.7 million barrels of oil equivalent. That’s a 2.7% climb from last year. Seems like CNOOC is really...

Ex-Guard Pushes Cost-Saving Grille Guards as Deer Season Hits

Deer Season's Bumper Problem If you're driving a hefty pickup or van in the thick of deer season, forget looking at pretty autumn leaves. Instead, brace for the telltale thud—and the ensuing financial headache—that comes with a deer collision. Anyone who's tangled with such a mishap knows it's not just about the dent in your fender; it's about your wallet getting...

Huawei's New O&M Strategies: A Game-Changer?

Huawei's Latest O&M Revolution: What's on the Table? With Huawei dropping fresh O&M solutions at HUAWEI CONNECT 2026 in Shanghai, they're not just shaking things up—they're kicking the whole operation management game into hyperdrive using AI. They're zeroing in on the whole digital twin strategy, boasting some nifty pre-event, in-process, and post-event capabilities to...

Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Sobi Names Börje Ekholm as Chair Amid New Data

An Offbeat Choice for Chair? So, Sobi's gone and picked Börje Ekholm as the proposed Chair of their Board. Now, this might raise some eyebrows out there—Ekholm's no stranger to top roles, having steered the ship at Ericsson. The twist here is usually these Chair announcements hum along without much fanfare, but chuck in Ekholm and you get a bit of buzz—probably...

Birth Injury Lawsuit Secures $19.1M Award in Michigan

Legal Triumph for Sokolove's Birth Injury Case There are days when you see a win in the courtroom and think maybe, just maybe, justice ain't just a fairytale. Today, that thought knocks heavier with news rolling out of Michigan—an astronomical $19.1 million awarded to a family by a federal judge after a botched birth led to lifelong medical issues. You've got Sokolove...

ACCULOAD: Aiming for Safer, Easier Boat Loading

Getting a boat onto a trailer? It can turn into a circus act if you're not careful. Visibility's shot, conditions change faster than a stock ticker, and alignment's like threading a needle blindfolded. Out comes ACCULOAD, a novel idea created by some intrepid inventor down in Slocomb, Ala, aiming to solve what’s been a pain point for boaters worldwide. What's ACCULOAD...

Foxconn Shakes Up EV Scene with New Models Unveiled

Foxconn Boldly Claims New Ground in EV Market Foxconn's at it again, thumping its chest in the electric vehicle arena with three fresh rides that scream ambition. At the HHTD26 in Taipei, they rolled out the MODEL A+, MODEL K+, and MODEL K—vehicles that not only diversify their portfolio but target segments that rarely see such a jolt. Does it get your gears turning?...